Quantifying Leg Muscle Deoxygenation During Incremental Cycling in Hypoxemic Patients with Fibrotic Interstitial Lung Disease
Overview
Physiology
Radiology
Affiliations
Background: Hypoxaemia and cardiocirculatory abnormalities may impair muscle oxygen (O ) delivery relative to O requirements thereby increasing the rate of O extraction during incremental exercise in fibrotic interstitial lung disease (f-ILD). Using changes in deoxyhaemoglobin concentration ([HHb]) by near-infrared spectroscopy (NIRS) as a proxy of O extraction, we investigated whether a simplified (double-linear) approach, previously tested in heart failure, would provide useful estimates of muscle deoxygenation in f-ILD.
Methods: A total of 25 patients (23 men, 72 ± 8 years; 20 with idiopathic pulmonary fibrosis, lung diffusing capacity for carbon monoxide = 44 ± 11% predicted) and 12 age- and sex-matched healthy controls performed incremental cycling to symptom limitation. Changes in vastus lateralis [HHb] assessed by NIRS were analysed in relation to work rate (WR) and O uptake throughout the exercise.
Results: Patients showed lower exercise capacity than controls (e.g., peak WR = 67 ± 18% vs. 105 ± 20% predicted, respectively; p < 0.001). The [HHb] response profile was typically S-shaped, presenting three distinct phases. Exacerbated muscle deoxygenation in patients versus controls was evidenced by: (i) a steeper mid-exercise [HHb]-WR slope (0.30 ± 0.22 vs. 0.11 ± 0.08 μmol/W; p = 0.008) (Phase 2), and (ii) a larger late-exercise increase in [HHb] (p = 0.002) (Phase 3). Steeper [HHb]-WR slope was associated with lower peak WR (r = -0.70) and greater leg discomfort (r = 0.77; p < 0.001) in f-ILD.
Conclusion: This practical approach to interpreting [HHb] during incremental exercise might prove useful to determine the severity of muscle deoxygenation and the potential effects of interventions thereof in hypoxemic patients with f-ILD.
Gonsard A, Mekov E, Barron S, Castellana G, Khurtsidze E, Vontetsianos A ERJ Open Res. 2024; 10(3).
PMID: 38770003 PMC: 11103686. DOI: 10.1183/23120541.00178-2024.
Smyth R, James M, Vincent S, Milne K, Marillier M, Domnik N Respir Care. 2023; 68(12):1662-1674.
PMID: 37643871 PMC: 10676244. DOI: 10.4187/respcare.11147.
Marillier M, Gruet M, Bernard A, Verges S, Moran-Mendoza O, Neder J ERJ Open Res. 2023; 9(3).
PMID: 37228269 PMC: 10204817. DOI: 10.1183/23120541.00726-2022.